Loading data
XPONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.16 bn USD | 8.07 bn USD | 7.74 bn USD | 7.72 bn USD | 7.2 bn USD |
| Selling, general and administrative expense | — | — | — | 678 m USD | 756 m USD |
| Operating profit | 656 m USD | 660 m USD | 438 m USD | 377 m USD | 312 m USD |
| Interest expense | — | — | 168 m USD | 135 m USD | 211 m USD |
| Profit before tax | 437 m USD | 473 m USD | 260 m USD | 258 m USD | 107 m USD |
| Income tax expense | 121 m USD | 86 m USD | 68 m USD | 74 m USD | 11 m USD |
| Net income (reported basis) | 316 m USD | 387 m USD | 189 m USD | 666 m USD | 336 m USD |
| Net income attributable to common shareholders | — | — | 189 m USD | 666 m USD | 336 m USD |
| Basic earnings per share | 2.69 USD/share | 3.33 USD/share | 1.64 USD/share | 5.79 USD/share | 2.99 USD/share |
| Diluted earnings per share | 2.64 USD/share | 3.23 USD/share | 1.6 USD/share | 5.76 USD/share | 2.93 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.